TWIST1 and neoplasm: To further validate whether Twist1 could promote NPC radioresistance in vivo, we employed a xenograft mouse model, where we injected CNE2-EV and CNE2-T cells to nude mice, and found the tumor sizes of the CNE2-T group were larger than those in the CNE2-EV group.